Aarti Pharmalabs reported a significant jump in H1 FY27 consolidated profit to Rs 147.61 crore from Rs 66.55 crore last year. Alongside the strong financial performance, the company announced a leadership change as CFO Piyush Lakhani steps down, with Vibha Thakkar appointed as his successor effective October 31, 2026. Shareholders should monitor an ongoing legal challenge regarding a Rs 59.5 crore stamp duty and penalty demand.
Aarti Pharmalabs Reports H1 Profit of Rs 147.61 Crore
Revenue for the half-year ended September 30, 2026, surged to Rs 1,146.25 crore.
Reader Takeaway: Strong operational growth marks H1 FY27, though legal uncertainty regarding stamp duty remains a key monitorable.
What just happened
Aarti Pharmalabs has released its financial results for the half-year ended September 30, 2026, showing a substantial improvement in profitability. Simultaneously, the company disclosed a management transition. Current CFO Piyush Lakhani will resign on October 30, 2026, to pursue other opportunities. He will be succeeded by Vibha Thakkar, a Chartered Accountant with 18 years of experience, on October 31, 2026.
Why this matters
The jump in consolidated net profit to Rs 147.61 crore from Rs 66.55 crore indicates strong demand and improved operational efficiency. The seamless transition of the CFO role is critical for maintaining investor confidence, particularly with the new appointee bringing experience from sectors like specialty chemicals and pharmaceuticals.
Risks to watch
The company is currently contesting a stamp duty order from the Gandhinagar authorities. The order demands Rs 25 crore in stamp duty plus Rs 34.50 crore in penalties. While the company has recognized a provision of Rs 2.04 crore, the remaining Rs 57.46 crore is classified as a contingent liability. The case is pending before the High Court of Gujarat, and its final outcome could impact the company's balance sheet.
What to track next
Investors should watch for updates on the High Court proceedings regarding the stamp duty demand. Furthermore, the market will monitor how the new CFO navigates the company's financial strategy following the recent period of significant growth.